StreetAlpha.app
Home › Stocks › BDX

Becton Dickinson & Co (BDX)

Healthcare
$212.78
▲ +0.05%
LAST CLOSE · NOV 20

Becton Dickinson makes medical devices and clinical diagnostic products for hospitals, researchers and other healthcare customers. It last closed at $212.78 on Nov 20, up 0.05% on the day. The next earnings report for BDX is expected around Mon, Feb 8, 2027. For the quarter ended Sep 2026, BDX reported adjusted EPS of $4.15 on revenue of $5.27B, with revenue down 36.5% from a year ago. Over its last 8 reports the stock moved an average of 5.2% the session after earnings. Over the last 12 months BDX insiders bought $0 of stock on the open market and sold $3.4M, according to SEC Form 4 filings.

AI Auto Pilots
Is BDX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BDX.

Key Stats

Last 12 months
Results
Revenue
$22.5B
+18.5% vs a year ago
Net income
$942.0M
−40.6% vs a year ago
EPS (diluted)
$3.31
−39.5% vs a year ago
Gross margin
46.9%
$10.6B gross profit
Valuation
Market cap
$58.0B
272.4M shares
P/E
64.3
Price over 12 month EPS
Price to sales
2.6
Market cap over revenue
Dividend yield
1.97%
$4.19 a share over 12 months
Balance sheet
Cash & equivalents
$708.0M
At Jun 30
Debt
$16.8B
At Jun 30
Shareholder equity
$24.4B
Buybacks
$2.5B
Last 12 months
Fiscal year endsSeptember
ExchangeNYSE
Financials history
FY2021: $19.1B$19.1BFY2021FY2022: $18.9B$18.9BFY2022FY2023: $19.4B$19.4BFY2023FY2024: $20.2B$20.2BFY2024FY2025: $21.8B$21.8BFY2025

From BDX's SEC filings, latest 10-Q for the period ending Jun 30, 2026 (filed Aug 6). Last 12 months adds up the four latest quarters.

Next report
Feb 8
Estimated date · Time not announced
Reported EPS
$4.15
Quarter ended Sep 2026 · adjusted
Year ago EPS
$1.72
+46.5% on a GAAP basis
Revenue
$5.27B
−36.5% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $1.04Dec '24Mar 2025: $1.07Mar '25Jun 2025: $2.00Jun '25Sep 2025: $1.72Sep '25Dec 2025: $1.34Dec '25Mar 2026: -$1.11Mar '26Jun 2026: $1.37Jun '26Sep 2026: $2.52Sep '26Latest $2.52
Revenue by quarter
Dec 2024: $5.17BDec '24Mar 2025: $4.48BMar '25Jun 2025: $4.73BJun '25Sep 2025: $8.30BSep '25Dec 2025: $5.25BDec '25Mar 2026: $4.71BMar '26Jun 2026: $4.98BJun '26Sep 2026: $5.27BSep '26Latest $5.27B
How BDX moved after its last 8 reports
Average move the session after a report ±5.2%
Nov 5, 2026Time not announced+2.1%
Aug 6, 2026Time not announced+3.8%
May 7, 2026Time not announced+5.9%
Apr 2, 2026After the close+0.5%
Feb 9, 2026Time not announced−1.3%
Oct 15, 2025After the close−0.8%
Aug 7, 2025Time not announced+8.9%
May 1, 2025Time not announced−18.1%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on BDXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on BDX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on BDX

Technical Analysis

BDX · as of the Nov 20 close · updated each morning
Uptrend, nearing overbought

The stock is 2% above its 20 day and 9% above its 50 day average. It is 20% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 63), near overbought. The nearest support is the Pivot S1 at $210.56, and the nearest resistance the Pivot at $213.54.

Short trendBullish
Long trendBullish
MomentumImproving
StretchNear overbought
VolatilityNormal, 2.1%/day
Key levels
$220.3652 week high+3.6%
$220.36Swing high (Nov 16)+3.6%
$215.76Pivot R1+1.4%
$213.54Pivot+0.4%
$212.78Last close
$210.56Pivot S1−1.0%
$208.1920 day average−2.2%
$194.4450 day average−8.6%
$193.80Swing low (Oct 28)−8.9%
$183.20100 day average−13.9%
$170.27200 day average−20.0%
$140.1152 week low−34.2%
Indicators
RSI (14)62.96Strong, overbought above 70Neutral
MACD6.26Below its signal lineBearish
Stochastic73.0Middle of its rangeNeutral
ADX (14)47.4Strong uptrend
Williams %R-31.4Oversold below −80, overbought above −20Neutral
CCI (20)48.4Oversold below −100, overbought above 100Neutral
Rate of change+0.4%Change over 10 sessionsBullish
ATR (14)$4.55Typical daily range, 2.1% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for BDX

What happened before

See how BDX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow BDX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How BDX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for BDXHow many large options trades hit BDX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

BDX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●661 buying vs 679 selling
  • ▼Held by funds -7.1 pts
  • ▲Funds holding +58
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,5011,443+4.0%
In funds' top 10149+55.6%
Held by funds94.9%102.0%−7.1 pts
New / increased167 / 494119 / 541+0.2%
Reduced / sold out578 / 101546 / 152−2.7%
Put/call ratio2.200.62+252.9%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BDX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

BDX Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$3.4M21 sales · 5 insiders
82% of the selling was under pre-arranged trading plans.
2025-12 sold $152K2026-01 sold $349K2026-02 sold $188K2026-03 sold $12K2026-04 sold $11K2026-05 sold $11K2026-06 sold $743K2026-07 sold $12K2026-08 sold $1.2M2026-09 sold $14K2026-10 sold $15K2026-11 sold $629KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 5Thomas E Polen JrChairman, CEO and PresidentSale plan2,993$210.00$629K
Oct 26Michael FeldEVP, Chief Revenue OfficerSale plan76$198.13$15K
Sep 28Michael FeldEVP, Chief Revenue OfficerSale plan76$183.70$14K
Aug 26Michael FeldEVP, Chief Revenue OfficerSale plan165$188.49$31K
Aug 13Thomas E Polen JrChairman, CEO and PresidentSale plan4,152$185.00$768K
Aug 11Roland GoetteEVP and President, EMEASale2,438$180.84$441K
Every insider buy and sale for BDX over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See BDX insider trades →

From SEC Form 4 filings by BDX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

BDX Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$2.5B
4.3% yield
Left in program
8.3M sh
3.0% of shares
Shares outstanding, 12 months
−5.0%
Fewer shares
Last quarter
$400.4M
Jun 2026
Avg price paid, last quarter
$124.58
3.2M shares bought
S&P 500 rank by spending
#91 of 358
 
Spent each quarter, last 3 yearsTop bar $1.6B
Sep 2023: $618K, average price $269.45Dec 2023: $500.3M, average price $236.06Mar 2024: $365K, average price $238.27Jun 2024: $359K, average price $233.20Sep 2024: $338K, average price $239.07Dec 2024: $607.7M, average price $230.36Mar 2025: $143.0M, average price $230.38Jun 2025: $286K, average price $198.59Sep 2025: $250.4M, average price $195.66Dec 2025: $250.3M, average price $190.06Mar 2026: $1.6B, average price $171.68Jun 2026: $400.4M, average price $124.58
Sep 2023Jun 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Aug 6, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BDX is in one of them and how their past BDX trades turned out.

BDX in the AI portfolios
Loading…

BDX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BDX in an article yet. Here's the latest on the wider market.

BDX in the news

BDX Congress Trades

All congress trades →
Trades, 12 months
4
Buys
2
50%
Sells
2
50%
People
4
Last filed Oct 7
Who traded BDX · since 2013
Latest 5 filings of 74
$1K – $15KTraded Sep 11, 2026Filed Oct 7, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
$1K – $15KTraded May 21, 2026Filed Jun 18, 2026
$15K – $50KTraded Mar 17, 2026Filed Apr 3, 2026
$1K – $15KTraded Jun 24, 2025Filed Aug 13, 2025
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KSep 11, 2026Oct 7, 202626 d
Alan ArmstrongR · OKBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d
Thomas KeanR · NJSell$1K – $15KMay 21, 2026Jun 18, 202628 d
Kevin HernR · OKSell$15K – $50KMar 17, 2026Apr 3, 202617 d
Lisa McClainR · MISell$1K – $15KJun 24, 2025Aug 13, 202550 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Becton Dickinson &

Becton Dickinson is a medical technology company based in Franklin Lakes, New Jersey. It makes medical devices and clinical diagnostic products used in healthcare settings. Its customers include hospitals and other healthcare providers, as well as pharmaceutical and biotechnology companies, academic institutions, government laboratories and private foundations that buy its products for research. A substantial part of its revenue comes from outside the United States.

Headquarters
Franklin Lakes, NJ
Founded
1897
Website
bd.com ↗